News Release |

3 February 2017

LexaGene is pleased to announce the appointment of Mr. Daryl Rebeck as President of the Company. Mr. Rebeck is currently a director of LexaGene and has accepted this new position as President effective January 1, 2017. Mr. Rebeck was instrumental in successfully executing the reverse takeover and thereby bringing LexaGene into the public sector. Jack Regan will remain Chief Executive Officer and Chairman of the board of directors for the Company, but has resigned as President.

VIEW RELEASE